The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125830332 12583033 2 F 20160421 20160714 20160722 20160729 EXP JP-CONCORDIA PHARMACEUTICALS INC.-CO-ZO-JP-2016-079 CONCORDIA 76.47 YR F Y 0.00000 20160729 PH JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125830332 12583033 1 PS ZONISAMIDE. ZONISAMIDE 1 Oral Y 20789 100 MG
125830332 12583033 2 I ZONISAMIDE. ZONISAMIDE 1 Oral Y 20789 200 MG
125830332 12583033 3 I ZONISAMIDE. ZONISAMIDE 1 Oral Y 20789 100 MG
125830332 12583033 4 I ZONISAMIDE. ZONISAMIDE 1 Oral Y 20789 200 MG
125830332 12583033 5 C LYRICA PREGABALIN 1 Oral 0 375 MG
125830332 12583033 6 C E KEPPRA LEVETIRACETAM 1 Oral 0 1000 MG
125830332 12583033 7 C HALCION TRIAZOLAM 1 Oral 0 .25 MG
125830332 12583033 8 C MAGMITT MAGNESIUM OXIDE 1 Oral 0 990 MG
125830332 12583033 9 C HORIZON DIAZEPAM 1 Oral 0 4 MG
125830332 12583033 10 C TSUMURA GOSHAJINKIGAN EXTRACT GRANULES FOR ETHICAL USE 2 Oral 0 5 G
125830332 12583033 11 C TSUMURA GOSHAJINKIGAN EXTRACT GRANULES FOR ETHICAL USE 2 0
125830332 12583033 12 C DRAMAMINE DIMENHYDRINATE 1 Oral 0 30 MG
125830332 12583033 13 C DRAMAMINE DIMENHYDRINATE 1 0
125830332 12583033 14 I TOFRANIL IMIPRAMINE HYDROCHLORIDE 1 Oral U 0 10 MG QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125830332 12583033 1 Epilepsy
125830332 12583033 5 Product used for unknown indication
125830332 12583033 6 Epilepsy
125830332 12583033 7 Insomnia
125830332 12583033 8 Constipation
125830332 12583033 9 Somatic symptom disorder
125830332 12583033 10 Pain in extremity
125830332 12583033 11 Anxiety
125830332 12583033 12 Dizziness
125830332 12583033 13 Anxiety
125830332 12583033 14 Depressive symptom

Outcome of event

Event ID CASEID OUTC COD
125830332 12583033 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125830332 12583033 Drug interaction
125830332 12583033 Hepatic function abnormal
125830332 12583033 Parkinsonism

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125830332 12583033 1 20071101 0
125830332 12583033 2 20151111 20151120 0
125830332 12583033 3 20151121 20160101 0
125830332 12583033 4 20160102 20160517 0
125830332 12583033 5 20160412 0
125830332 12583033 6 20151113 0
125830332 12583033 7 20151224 0
125830332 12583033 8 20160107 0
125830332 12583033 9 20160313 0
125830332 12583033 10 20160413 20160517 0
125830332 12583033 12 20160514 20160520 0
125830332 12583033 14 20160412 20160516 0